Should patients evaluated for chest pain at the ED receive cardiac testing?
American College of Cardiology News Jul 07, 2017
Routine cardiac testing may not be warranted for patients who present to the emergency department (ED) for chest pain without a diagnosis consistent with acute coronary syndrome (ACS). The findings of the retrospective cohort analysis were published June 26 in JAMA Internal Medicine journal.
Alex Sandhu, MD, et al., analyzed national claims data for 926,633 privately insured patients using Truven MarketScan. The patients were aged 18–64 years (average age, 44 years; 59 percent women) who visited an ED between 2011 and 2012.
Results showed an increase in the use of downstream testing and treatment in patients who underwent noninvasive testing and coronary angiography for chest pain in the ED Â but no reduction in hospital admissions for an acute myocardial infarction (AMI).
Previously, cardiac testing rates were assumed to be higher on weekdays due to differences in resource availability. To address unmeasured cofounding in the observational data, the researchers used the day of presentation, weekday (Monday through Thursday) vs. weekend (Friday through Sunday), as an instrumental variable in their analysis.
While similar baseline comorbidities were found between the two groups, patients who presented to the ED on a weekday (n = 571,988) were more likely than those who presented over the weekend (n = 354,645) to receive testing within two days (18.1 percent vs. 12.3 percent) or 30 days (26.1 percent vs. 21.35 percent).
After risk factor adjustment, testing within 30 days was associated with an increase in coronary angiography (36.5 per 1000 patients tested) and revascularization (22.8 per 1000 patients tested) at one year, while AMI admissions was not. Similar results were seen in patients who received testing within two days.
The study authors conclude that "further analysis of the effect of testing on health care utilization and costs will refine future practice recommendations and guide patient–physician shared decision–making." They state that "the current evidence supports a shift in the treatment of these patients; shared decision–making with patients should be considered a viable alternative to routine cardiac testing in the absence of robust evidence to support its benefit."
Go to Original
Alex Sandhu, MD, et al., analyzed national claims data for 926,633 privately insured patients using Truven MarketScan. The patients were aged 18–64 years (average age, 44 years; 59 percent women) who visited an ED between 2011 and 2012.
Results showed an increase in the use of downstream testing and treatment in patients who underwent noninvasive testing and coronary angiography for chest pain in the ED Â but no reduction in hospital admissions for an acute myocardial infarction (AMI).
Previously, cardiac testing rates were assumed to be higher on weekdays due to differences in resource availability. To address unmeasured cofounding in the observational data, the researchers used the day of presentation, weekday (Monday through Thursday) vs. weekend (Friday through Sunday), as an instrumental variable in their analysis.
While similar baseline comorbidities were found between the two groups, patients who presented to the ED on a weekday (n = 571,988) were more likely than those who presented over the weekend (n = 354,645) to receive testing within two days (18.1 percent vs. 12.3 percent) or 30 days (26.1 percent vs. 21.35 percent).
After risk factor adjustment, testing within 30 days was associated with an increase in coronary angiography (36.5 per 1000 patients tested) and revascularization (22.8 per 1000 patients tested) at one year, while AMI admissions was not. Similar results were seen in patients who received testing within two days.
The study authors conclude that "further analysis of the effect of testing on health care utilization and costs will refine future practice recommendations and guide patient–physician shared decision–making." They state that "the current evidence supports a shift in the treatment of these patients; shared decision–making with patients should be considered a viable alternative to routine cardiac testing in the absence of robust evidence to support its benefit."
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
